Back to search

Article

Solriamfetol enhances alertness and cognitive performance in mice

2025-01-02

Abstract excerpt

Solriamfetol [(R)-2-amino-3-phenylpropylcarbamate hydrochloride], a phenylalanine derivative initially developed as potential antidepressant, was shown by our group in 2009 to have potent, dose-dependent wake-promoting activity in mice. Solriamfetol (Sunosi ® ) is used since 2019 to counteract excessive daytime sleepiness (EDS) in patients with narcolepsy and obstructive sleep apnea (OSA). It has several advantag...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
3f931c65-489e-53c9-86db-d4348dd0ee1c
DOI
10.1101/2025.01.02.631072
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Solriamfetol enhances alertness and cognitive performance in miceDOI 10.1101/2025.01.02.631072
Select a neighboring publication to make it the new centre.